Abstract 2330: MCT inhibition as a therapeutic strategy to target Enzalutamide-resistant prostate cancer

Authors:

Published: 2021-07-01

DOI: 10.1158/1538-7445.am2021-2330

Source: Full article

---

Abstract

Abstract